Regulated Electric
Compare Stocks
5 / 10Stock Comparison
EXC vs GE vs EMR vs RTX vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
Aerospace & Defense
Industrial - Machinery
Aerospace & Defense
Conglomerates
EXC vs GE vs EMR vs RTX vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Regulated Electric | Aerospace & Defense | Industrial - Machinery | Aerospace & Defense | Conglomerates |
| Market Cap | $45.43B | $316.20B | $79.02B | $238.07B | $136.91B |
| Revenue (TTM) | $24.79B | $48.35B | $18.32B | $90.37B | $36.76B |
| Net Income (TTM) | $2.78B | $8.66B | $2.44B | $7.26B | $4.10B |
| Gross Margin | 29.5% | 34.8% | 52.7% | 20.2% | 36.9% |
| Operating Margin | 21.0% | 18.5% | 19.8% | 10.4% | 14.9% |
| Forward P/E | 15.6x | 40.0x | 21.7x | 25.5x | 20.5x |
| Total Debt | $50.55B | $20.49B | $13.76B | $39.51B | $34.58B |
| Cash & Equiv. | $1.15B | $12.39B | $1.54B | $7.43B | $12.49B |
EXC vs GE vs EMR vs RTX vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Exelon Corporation (EXC) | 100 | 162.6 | +62.6% |
| GE Aerospace (GE) | 100 | 925.2 | +825.2% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| RTX Corporation (RTX) | 100 | 274.0 | +174.0% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXC vs GE vs EMR vs RTX vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXC is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 2.44 vs HON's 11.18
- Lower P/E (15.6x vs 25.5x)
- 3.6% yield, 1-year raise streak, vs EMR's 1.5%
GE carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 18.5%, EPS growth 36.2%, 3Y rev CAGR 16.3%
- 18.5% revenue growth vs EMR's 3.0%
- 17.9% margin vs RTX's 8.0%
- +44.9% vs EXC's -0.7%
EMR lags the leaders in this set but could rank higher in a more targeted comparison.
RTX ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- 234.7% 10Y total return vs EMR's 206.6%
- Lower volatility, beta 0.51, Low D/E 58.8%, current ratio 1.03x
- Beta 0.51 vs EMR's 1.52, lower leverage
HON is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Beta 0.74, yield 2.1%, current ratio 1.32x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.5% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (15.6x vs 25.5x) | |
| Quality / Margins | 17.9% margin vs RTX's 8.0% | |
| Stability / Safety | Beta 0.51 vs EMR's 1.52, lower leverage | |
| Dividends | 3.6% yield, 1-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +44.9% vs EXC's -0.7% | |
| Efficiency (ROA) | 6.8% ROA vs EXC's 2.4%, ROIC 24.7% vs 5.1% |
EXC vs GE vs EMR vs RTX vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EXC vs GE vs EMR vs RTX vs HON — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EXC leads in 2 of 6 categories
GE leads 2 • EMR leads 0 • RTX leads 0 • HON leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — GE and EMR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RTX is the larger business by revenue, generating $90.4B annually — 4.9x EMR's $18.3B. GE is the more profitable business, keeping 17.9% of every revenue dollar as net income compared to RTX's 8.0%. On growth, GE holds the edge at +24.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $24.8B | $48.4B | $18.3B | $90.4B | $36.8B |
| EBITDAEarnings before interest/tax | $8.9B | $9.9B | $4.7B | $13.8B | $6.5B |
| Net IncomeAfter-tax profit | $2.8B | $8.7B | $2.4B | $7.3B | $4.1B |
| Free Cash FlowCash after capex | -$2.2B | $7.5B | $3.1B | $8.4B | $4.2B |
| Gross MarginGross profit ÷ Revenue | +29.5% | +34.8% | +52.7% | +20.2% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +21.0% | +18.5% | +19.8% | +10.4% | +14.9% |
| Net MarginNet income ÷ Revenue | +11.2% | +17.9% | +13.3% | +8.0% | +11.2% |
| FCF MarginFCF ÷ Revenue | -8.7% | +15.4% | +17.0% | +9.2% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.9% | +24.7% | +2.9% | +8.7% | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | -1.1% | +28.2% | +32.5% | -41.9% |
Valuation Metrics
EXC leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 16.2x trailing earnings, EXC trades at a 56% valuation discount to GE's 37.1x P/E. Adjusting for growth (PEG ratio), EXC offers better value at 2.54x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $45.4B | $316.2B | $79.0B | $238.1B | $136.9B |
| Enterprise ValueMkt cap + debt − cash | $94.8B | $324.3B | $91.2B | $270.1B | $159.0B |
| Trailing P/EPrice ÷ TTM EPS | 16.21x | 37.09x | 34.92x | 35.64x | 29.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.57x | 40.02x | 21.71x | 25.54x | 20.52x |
| PEG RatioP/E ÷ EPS growth rate | 2.54x | 3.14x | 7.73x | — | 15.99x |
| EV / EBITDAEnterprise value multiple | 10.79x | 32.46x | 18.07x | 20.96x | 19.99x |
| Price / SalesMarket cap ÷ Revenue | 1.87x | 6.90x | 4.39x | 2.69x | 3.66x |
| Price / BookPrice ÷ Book value/share | 1.56x | 17.09x | 3.94x | 3.57x | 9.00x |
| Price / FCFMarket cap ÷ FCF | — | 43.53x | 29.63x | 29.98x | 25.39x |
Profitability & Efficiency
GE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GE delivers a 45.8% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $10 for EXC. RTX carries lower financial leverage with a 0.59x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), RTX scores 8/9 vs EXC's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.8% | +45.8% | +12.1% | +10.9% | +23.1% |
| ROA (TTM)Return on assets | +2.4% | +6.8% | +5.8% | +4.3% | +5.3% |
| ROICReturn on invested capital | +5.1% | +24.7% | +8.2% | +6.7% | +12.6% |
| ROCEReturn on capital employed | +5.0% | +9.6% | +10.0% | +7.9% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 8 | 6 |
| Debt / EquityFinancial leverage | 1.76x | 1.08x | 0.68x | 0.59x | 2.24x |
| Net DebtTotal debt minus cash | $49.4B | $8.1B | $12.2B | $32.1B | $22.1B |
| Cash & Equiv.Liquid assets | $1.2B | $12.4B | $1.5B | $7.4B | $12.5B |
| Total DebtShort + long-term debt | $50.6B | $20.5B | $13.8B | $39.5B | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | 2.42x | 11.69x | 6.46x | 5.58x | 3.92x |
Total Returns (Dividends Reinvested)
GE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GE five years ago would be worth $46,249 today (with dividends reinvested), compared to $10,326 for HON. Over the past 12 months, GE leads with a +44.9% total return vs EXC's -0.7%. The 3-year compound annual growth rate (CAGR) favors GE at 56.0% vs EXC's 4.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.1% | -5.5% | +4.3% | -5.2% | +10.9% |
| 1-Year ReturnPast 12 months | -0.7% | +44.9% | +30.4% | +40.8% | +2.8% |
| 3-Year ReturnCumulative with dividends | +14.6% | +280.0% | +75.9% | +93.0% | +16.2% |
| 5-Year ReturnCumulative with dividends | +61.8% | +362.5% | +59.5% | +120.1% | +3.3% |
| 10-Year ReturnCumulative with dividends | +125.0% | +121.0% | +206.6% | +234.7% | +135.1% |
| CAGR (3Y)Annualised 3-year return | +4.7% | +56.0% | +20.7% | +24.5% | +5.1% |
Risk & Volatility
EXC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EXC is the less volatile stock with a -0.14 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EXC currently trades 87.7% from its 52-week high vs RTX's 82.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.14x | 1.14x | 1.52x | 0.51x | 0.74x |
| 52-Week HighHighest price in past year | $50.65 | $348.48 | $165.15 | $214.50 | $248.18 |
| 52-Week LowLowest price in past year | $41.71 | $208.22 | $108.37 | $126.03 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +87.7% | +86.8% | +85.4% | +82.4% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 33.7 | 56.4 | 61.3 | 37.3 | 45.1 |
| Avg Volume (50D)Average daily shares traded | 8.3M | 5.7M | 2.8M | 5.3M | 3.7M |
Analyst Outlook
Evenly matched — EXC and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EXC as "Hold", GE as "Buy", EMR as "Buy", RTX as "Buy", HON as "Buy". Consensus price targets imply 27.6% upside for GE (target: $386) vs 10.7% for EXC (target: $49). For income investors, EXC offers the higher dividend yield at 3.60% vs GE's 0.45%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $49.18 | $386.20 | $161.92 | $224.89 | $243.83 |
| # AnalystsCovering analysts | 35 | 34 | 41 | 26 | 28 |
| Dividend YieldAnnual dividend ÷ price | +3.6% | +0.4% | +1.5% | +1.5% | +2.1% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 37 | 4 | 15 |
| Dividend / ShareAnnual DPS | $1.60 | $1.36 | $2.10 | $2.63 | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.4% | +1.6% | +0.0% | +2.8% |
EXC leads in 2 of 6 categories (Valuation Metrics, Risk & Volatility). GE leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
EXC vs GE vs EMR vs RTX vs HON: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EXC or GE or EMR or RTX or HON a better buy right now?
For growth investors, GE Aerospace (GE) is the stronger pick with 18.
5% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Exelon Corporation (EXC) offers the better valuation at 16. 2x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate GE Aerospace (GE) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXC or GE or EMR or RTX or HON?
On trailing P/E, Exelon Corporation (EXC) is the cheapest at 16.
2x versus GE Aerospace at 37. 1x. On forward P/E, Exelon Corporation is actually cheaper at 15. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Exelon Corporation wins at 2. 44x versus Honeywell International Inc. 's 11. 18x.
03Which is the better long-term investment — EXC or GE or EMR or RTX or HON?
Over the past 5 years, GE Aerospace (GE) delivered a total return of +362.
5%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: RTX returned +234. 7% versus GE's +121. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXC or GE or EMR or RTX or HON?
By beta (market sensitivity over 5 years), Exelon Corporation (EXC) is the lower-risk stock at -0.
14β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately -1184% more volatile than EXC relative to the S&P 500. On balance sheet safety, RTX Corporation (RTX) carries a lower debt/equity ratio of 59% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EXC or GE or EMR or RTX or HON?
By revenue growth (latest reported year), GE Aerospace (GE) is pulling ahead at 18.
5% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: RTX Corporation grew EPS 39. 7% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, GE leads at 16. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXC or GE or EMR or RTX or HON?
GE Aerospace (GE) is the more profitable company, earning 19.
0% net margin versus 7. 6% for RTX Corporation — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXC leads at 21. 2% versus 10. 0% for RTX. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXC or GE or EMR or RTX or HON more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Exelon Corporation (EXC) is the more undervalued stock at a PEG of 2. 44x versus Honeywell International Inc. 's 11. 18x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Exelon Corporation (EXC) trades at 15. 6x forward P/E versus 40. 0x for GE Aerospace — 24. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GE: 27. 6% to $386. 20.
08Which pays a better dividend — EXC or GE or EMR or RTX or HON?
All stocks in this comparison pay dividends.
Exelon Corporation (EXC) offers the highest yield at 3. 6%, versus 0. 4% for GE Aerospace (GE).
09Is EXC or GE or EMR or RTX or HON better for a retirement portfolio?
For long-horizon retirement investors, Exelon Corporation (EXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
14), 3. 6% yield, +125. 0% 10Y return). Both have compounded well over 10 years (EXC: +125. 0%, GE: +121. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXC and GE and EMR and RTX and HON?
These companies operate in different sectors (EXC (Utilities) and GE (Industrials) and EMR (Industrials) and RTX (Industrials) and HON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EXC is a mid-cap deep-value stock; GE is a large-cap high-growth stock; EMR is a mid-cap quality compounder stock; RTX is a large-cap quality compounder stock; HON is a mid-cap quality compounder stock. EXC, EMR, RTX, HON pay a dividend while GE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.